Title:
HEPATITIS C VIRUS INHIBITORS
Document Type and Number:
WIPO Patent Application WO2004032827
Kind Code:
A3
Abstract:
The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
Inventors:
RIPKA AMY (US)
CAMPBELL JEFFREY ALLEN (US)
GOOD ANDREW CHARLES (US)
SCOLA PAUL MICHAEL (US)
SIN NY (US)
VENABLES BRIAN (US)
CAMPBELL JEFFREY ALLEN (US)
GOOD ANDREW CHARLES (US)
SCOLA PAUL MICHAEL (US)
SIN NY (US)
VENABLES BRIAN (US)
Application Number:
PCT/US2003/015856
Publication Date:
October 14, 2004
Filing Date:
May 20, 2003
Export Citation:
Assignee:
BRISTOL MYERS SQUIBB CO (US)
RIPKA AMY (US)
CAMPBELL JEFFREY ALLEN (US)
GOOD ANDREW CHARLES (US)
SCOLA PAUL MICHAEL (US)
SIN NY (US)
VENABLES BRIAN (US)
RIPKA AMY (US)
CAMPBELL JEFFREY ALLEN (US)
GOOD ANDREW CHARLES (US)
SCOLA PAUL MICHAEL (US)
SIN NY (US)
VENABLES BRIAN (US)
International Classes:
A61K31/40; A61K38/06; C07D207/04; C07K5/078; (IPC1-7): C07D207/04; A61K31/40
Foreign References:
| US6323180B1 | 2001-11-27 | |||
| US6265380B1 | 2001-07-24 | |||
| US6225284B1 | 2001-05-01 |
Other References:
See also references of EP 1506172A4
Download PDF: